ResearcherUniversity of MalayaNo recent work listed
Chung Yeng Looi
Matched on ORCID iD 0000-0002-4830-3495; OpenAlex author ID A5053135777. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2016: 1 paper · 2017: 1 paper
Papers 2
- Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cel… Last author DOI 10.1016/j.bbagen.2016.10.006↗
- Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification. First author DOI 10.18632/oncotarget.9165↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuan Seng Wu · 2 shared papers, 2016–2017 · strength 0.16
- Paper Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Sta… DOI 10.1016/j.bbagen.2016.10.006↗
- Paper Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramm… DOI 10.18632/oncotarget.9165↗
- Ivy Chung · 2 shared papers, 2016–2017 · strength 0.16
- Paper Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Sta… DOI 10.1016/j.bbagen.2016.10.006↗
- Paper Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramm… DOI 10.18632/oncotarget.9165↗
- Atsushi Masamune · 2 shared papers, 2016–2017 · strength 0.16
- Paper Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Sta… DOI 10.1016/j.bbagen.2016.10.006↗
- Paper Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramm… DOI 10.18632/oncotarget.9165↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.